Biogen Message Board - Msg: 8053083

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 159.65

+2.2%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (882)	2/26/1999 12:46:00 PM
From: scaram(o)uche	Read Replies (3) of 1686

Great find, PB. Thanks. >> The repeat-dose regimen produced a longer terminal half-life (500 h) and lower clearance (0.13 ml.h-1.kg-1) than in the single-dose groups. << Yeah, but, but, but..... what the hell happens on rechallenge after a rest of, say, 21 days or more??????? Arrrrrgh..... been waiting to see chimeric versus humanized compared in monkeys, and..... the damn study doesn't tell us what happened! Arrrrrrrrrrrrrgggggggggggghhhhhhhhhhhhhhhhh...........

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next